Chemistry & Biology
Volume 19, Issue 11, 21 November 2012, Pages 1358-1359
Journal home page for Chemistry & Biology

Preview
A Kick-Start for CLC Antiporters’ Pharmacology

https://doi.org/10.1016/j.chembiol.2012.10.009Get rights and content
Under an Elsevier user license
open archive

Despite the role of chloride channels and anion/proton antiporters of the CLC protein family in physiological processes and different genetic diseases, their pharmacology has been under-developed. In this issue of Chemistry & Biology, Howery et al. report the synthesis of 4′-octanamidostilbene-2,2′-disulfonate, the first high-affinity inhibitor of a CLC antiporter, a critical step toward reviving the CLC pharmacology.

Cited by (0)